Literature DB >> 17700705

Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.

Y Miura1, K Yoshida, T Nishimoto, K Hatanaka, S Ohnami, M Asaka, J T Douglas, D T Curiel, T Yoshida, K Aoki.   

Abstract

Targeting of gene transfer at the level of cell entry is one of the most attractive challenges in vector development. However, attempts to redirect adenovirus vectors to alternative receptors by engineering the capsid-coding region have shown limited success because proper targeting ligand-receptor systems on the cells of interest are generally unknown. Systematic approaches to generate adenovirus vectors targeting any given cell type need to be developed to achieve this goal. Here, we constructed an adenovirus library that was generated by a Cre-lox-mediated in vitro recombination between an adenoviral fiber-modified plasmid library and genomic DNA to display random peptides on a fiber knob. As proof of concept, we screened the adenovirus display library on a glioma cell line and observed selection of several particular peptide sequences. The targeted vector carrying the most frequently isolated peptide significantly enhanced gene transduction in the glioma cell line but not in many other cell lines. Because the insertion of a pre-selected peptide into a fiber knob often fails to generate an adenovirus vector, the selection of targeting peptides is highly useful in the context of the adenoviral capsid. This vector-screening system can facilitate the development of a targeted adenovirus vector for a variety of applications in medicine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700705     DOI: 10.1038/sj.gt.3303007

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

1.  Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.

Authors:  Ping Wu; Tarana A Kudrolli; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Shawn E Lupold
Journal:  Cancer Res       Date:  2010-07-29       Impact factor: 12.701

2.  Infectivity-selective oncolytic adenovirus developed by high-throughput screening of adenovirus-formatted library.

Authors:  Yoshiaki Miura; Satoshi Yamasaki; Julia Davydova; Eric Brown; Kazunori Aoki; Selwyn Vickers; Masato Yamamoto
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

Review 3.  Chapter two--Adenovirus strategies for tissue-specific targeting.

Authors:  Matthew S Beatty; David T Curiel
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

4.  Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.

Authors:  Yuki Yamamoto; Naoko Goto; Kazuki Miura; Kenta Narumi; Shumpei Ohnami; Hiroaki Uchida; Yoshiaki Miura; Masato Yamamoto; Kazunori Aoki
Journal:  Mol Pharm       Date:  2014-01-24       Impact factor: 4.939

5.  Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer.

Authors:  Satoshi Yamasaki; Yoshiaki Miura; Julia Davydova; Selwyn M Vickers; Masato Yamamoto
Journal:  Int J Cancer       Date:  2012-12-21       Impact factor: 7.396

6.  Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.

Authors:  M A Tyler; I V Ulasov; A M Sonabend; S Nandi; Y Han; S Marler; J Roth; M S Lesniak
Journal:  Gene Ther       Date:  2008-12-11       Impact factor: 5.250

Review 7.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

8.  Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.

Authors:  Michael A van Geer; Conny T Bakker; Naoya Koizumi; Hiroyuki Mizuguchi; John G Wesseling; Ronald P J Oude Elferink; Piter J Bosma
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

9.  Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.

Authors:  Takeshi Nishimoto; Yuki Yamamoto; Kimiko Yoshida; Naoko Goto; Shumpei Ohnami; Kazunori Aoki
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

10.  Directed adenovirus evolution using engineered mutator viral polymerases.

Authors:  Taco G Uil; Jort Vellinga; Jeroen de Vrij; Sanne K van den Hengel; Martijn J W E Rabelink; Steve J Cramer; Julia J M Eekels; Yavuz Ariyurek; Michiel van Galen; Rob C Hoeben
Journal:  Nucleic Acids Res       Date:  2010-12-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.